Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB x NZW)F1 pre-B cells by unknown
Development ofAutoimmune Disease in SCID Mice
Populated with LongTerm "In Vitro" Proliferating
(NZB x NZW)F1 Pre-B Cells
By Luc Reininger, Thaddaus Radaszkiewicz,* Marie Kosco,
Fritz Melchers, and Anton G . Rolink
From the Basel Institute for Immunology, CH-4058 Basel, Switzerland and *The Institute of
Pathology, University of Vienna, A1090 Vienna, Austria
Summary
Pre-B cell lines proliferating for several months on stromal cells in the presence of interleukin
7 (IL7) were established from fetal liver of (NZB x NZW)Fi mice. They express the B lineage-
specific markers PB76, B220, and VpreB, but do not express surface immunoglobulin (sIg) . Upon
removal of IL-7 from the culture, they differentiate to sIg ` B cells that can then be stimulated
by lipopolysaccharide to become IgM-secreting cells. Transfer of these pre-B cell lines into SCID
mice leads to hypergammaglobulinemia ofIgM (600-900 , ug/ml), IgG2a (1-3 mg/ml), andIgG3
(300-500 Ag/ml) for the next 3-5 mo. The spleen appears populated with (NZB x NZW)Fl-
derived pre-B cells, few B cells, and many IgM and/or IgG-producing plasma cells. In contrast,
SCID mice populated with pre-B cell lines of normal (C57BL/6 x DBA/2)Fl mouse fetal liver
develop normal levels of serum IgM (ti100-300 Itg/ml), almost no detectable levels of IgG,
and no plasma cell hyperplasia . The (NZB x NZW)Fi pre-13 cell-populated SCID mice contain
elevated serum titers of IgG antinuclear autoantibodies, but no retroviral gp70-specific nor
erythrocyte-specific autoantibodies. Up to 20% of the SCID mice develop proteinuria as a
consequence of IgG deposits in the kidney glomeruli during a 7-mo period of observation. All
signs of autoimmune disease seen in these mice are independent of the sex of the SCID host .
This experimental system provides a distinction between the disease-determining (NZB x
NZW)F, genes, which are expressed in the B lymphocyte lineage and cause the development
of the disease, from those expressed in other cell lineages which only modulate its progression .
lNZB x NZW)Fj (B/W) hybrid mice spontaneously
1`
develop an autoimmune disease closely resembling
human SLE . It is characterized by elevated serum levels of
IgG antinuclear antibodies (ANA)' specific for DNA and
histones as well as by IgG antiretroviral envelope glycopro-
tein gp70 antibodies that have been implied in the develop-
ment ofa fatal immune complex-mediated glomerulonephritis
(1-8) . Several other immunological abnormalities have been
shown to affect B/W mice, such as increased spontaneous
polyclonal B cell activation with elevated levels of IgM that
occurs even at birth, early switches to IgG with elevated levels
of IgG2a and resistance to tolerance induction (9-15) . Fe-
male mice develop the switch to IgG autoantibodies and the
final renal disease earlier than male mice (14, 15) . In the pa-
rental NZB strain of mice, precursor B cell development is
1 Abbreviations used in this paper. ANA, antinuclear antibodies ; MRBC,
anti-mouse red blood cells ; MuLV, murine leukemia virus .
enhanced and accelerated (16, 17) . Similar abnormalities affect
the B cells from other mice with SLE-like disease (10, 11,
18) . Altogether, these observations suggest that an excessive
B cell activity could be the primary immunological abnor-
mality in New Zealand mice and other strains of mice with
spontaneous autoimmune disease . The possibility to accelerate
the autoimmune disease of autoimmune-prone mice by poly-
clonal B cell stimulators supports this idea (19) .
Multiple genes appear to be responsible for the manifesta-
tion of the disease in B/W mice. They are contributed either
from the parental NZB or NZW genome, their gene prod-
ucts can enhance or suppress the disease, and they may be
expressed in different cell lineages (8, 20-27) . It has been
demonstrated that the B/W autoimmune disease can be trans-
ferred into normal hosts with hematopoietic stem cells or
lymphoid precursors, which suggests that abnormalities
leading to autoimmune disease are expressed in these cells
(28) . Nevertheless, one could not distinguish abnormalities
that are intrinsic to B lineage cells from those of other cell
populations that regulate B cell activation and differentia-
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abnormalities expressed in B lineage cells alone suffice to de-
velop autoimmune disease. It is notable that alterations ex-
pressed in stromal cells on the level of pre-B cell regulation
(29) or in T cells or monocytes/macrophages on the level
ofB cell regulation could be responsible for the autoimmu-
nity and immunopathology seen in B/W mice. Indeed, the
involvementofTcells hasbeen suggested by the finding that
anti-CD4 treatment ofB/W mice couldprevent the sponta-
neous formation of antinuclear antibody andthe development
of renal disease (30) . It has also been shown that the genes
from NZW, which contribute in a major way to the devel-
opment of the renal disease in theB/W hybrid mouse, are
closelylinked to theMHClocus (27, 31) . Since genes of the
MHC locus are involved in the selection of the T cell reper-
toire, the latter findingmay suggest that either B/WT cells
or othergeneswith functions in theimmune system encoded
in this chromosomalregion expressedin non-B lineage cells,
contribute to the development ofautoimmune disease. It is
still unknown which of the B cell abnormalities are impor-
tant for the disease and which may be a consequence of the
disease rather than the cause for it .
Recently it was shown that murine fetal liver cells expressing
early B lineage-related markers such as PB76, Vp,,B and X5
can be isolated and cultured as long-term proliferatingpre-B
cell lines and clones (32) . The proliferating cells are DJ"
rearranged on both alleles, but most of them do not have
VD,J rearrangements and have both L chain gene loci (tc
and X) in germline configuation . When IL-7 is removed, they
can differentiate in vitro within 2-3 d to sIg+, have both
L chain gene loci LPS-reactive B cells . They can also stably
populate lymphoid organs of SCID mice with pre-B cells
and sIg+, LPS-reactive B cells over a period of more than
25 wk (32) . We describe here theestablishment of such pre-
B cell lines andclones from B/Wmice. The transfer ofthese
pre-B cells into SCID mice is used to study the contribution
of the B cell compartment to this autoimmune disease.
Materials and Methods
Mice and Cell Transfer .
￿
C57BL/6, DBA/2, NZB, and NZW
mice were obtained from the Institut fur Medizinische Forschung
AG (Rillinsdorf, Switzerland) . B/W embryos from pregnantNZB
females mated withNZW male mice were provided by breeding
facilities at the Basel Institute forImmunology. CB17 SCID mice
were bred at our own animal facilities from breeding pairs origi-
nally obtained fromM. Bosma (Institute for Cancer Research, Fox
Chase, Philadelphia, PA) and were routinely tested for serum Ig
before use. 2-3-mo-old CB17SCID mice were irradiated with 300
rad and, 4-6 h after irradiation, injected intravenously with 5-15
x 106 pre-B cells.
Monoclonal Antibodies.
￿
The following mAbs were used: G-5-2
(anti-PB76) (33) ; 14.8 (anti-B220) (34) ; M41 (anti-mouse A) (35) ;
187.1 (anti-mouse tc) (36) ; GK1.5 (anti-mouse CD4) (37) ;andLyt2
53.6.7 (anti-mouseCD8) (38) . Preparation and purification of the
mAbs were described previously (32) .
Establishment of Pre-B Cell Lines and Tissue Culture Condi-
tions. Isolation of mouse fetal liver pre-B cell lines was previously
described in detail (32). In the present study, fetal liver cells at day
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17 of gestationfrom pregnant NZBfemale mice matedwithNZW
male mice were directly cloned in 96-well flat-bottomed microcul-
ture plates at a concentration of 50 nucleated cells/ml on a
semiconfluent layer of3,000 rad x-irradiated stromal cells in serum-
substitutedIMDM (39) containing 100-200U/ml IL-7 . The pre-B
cells were routinely subcultured every 3 d on stromal cells and IL-7
in 75 cmz tissue culture flasks at a density of 2 x 106 pre-B
cells/25 ml . In vitro differentiation to sIg' cells was performed
in culture with stromal cells but without IL-7 for 3-4 d . Ig-secreting
cells were induced in these cultures by the addition of 50 tig/ml
LPS (S form of Salmonella abortus equi) for 7 d . The number of
IgM- and IgG-secreting cells was determined using the protein A
plaque assay as described by Gronowicz et al . (40) .
Cell Staining .
￿
Forimmunofluorescence analysis we used purified
mAbs coupled to biotin and FITC-labeled streptavidin (Radiochem-
ical Centre, Amersham International, Amersham, Bucks, UK).
Staining of the cells was done as described by Rolink et al . (41) .
Fluorescence intensitywasmeasured with a FACScan® instrument
(Becton Dickinson & Co., Mountain View, CA).
Quantitation of Ig Levels and Determination of the IgG2a Allo-
types. Total levels of serumIgM, IgG1, IgG2a, IgG2b, IgG3, and
IgAwere determined by ELISA as previously described (42) . Briefly,
ELISA plates were coated overnight at 4°C with goat anti-mouse
IgM + IgG (H + L chain) or goat anti-mouse IgA antibodies
(Southern Biotechnology Associates Inc., Birmingham, AL) at a
concentration of 5 lag/ml . After several washings in PBS, dilutions
oftheserumsamples in PBS containing 0.2% Tween 20, 4% BSA,
0.2% azide were incubated on the coated plates for2 h. This was
followed by several washings in PBS. The plates were then incubated
with alkaline phosphatase-labeled goat antibodies specific for mouse
Ig classesand subclasses (purchased from Southern Biotechnology
Associates Inc.) diluted 1:500 in PBS containing 0.2% Tween 20,
4% BSA, 0.2% azide for 2 h, washed again several times with
PBS, and then developedwith paranitrophenyl phosphate (1 mg/ml)
(Sigma Chemical Co., St . Louis, MO). The plates were read for
paranitrophenol developed in the reaction on a microplate reader
(Thermomax ; MolecularDevices Corporation, Menlo Park, CA).
TheIgM, IgG subclasses and IgA concentrations were computed
(Softmax program ; Molecular Devices Corporation) by referring
to standard curves obtained with known concentrations of mouse
Ig (Southern Biotechnology Associates Inc.).
An ELISA described elsewhere (43) wasused to determine serum
IgG2a of the Igh, and Ighb allotypes. Igs from each serum sample
were first separatedby precipitation in ammonium sulfate at 50%
saturation . The precipitates were resuspended in carbonate buffer
0.05 M, pH 9.5 and were used for coating microplates (Linbro;
Flow Laboratories, Inc., McLean, VA) at a final dilution of 1:1,000
overnight at 4°C . The plates were then incubated for 2 h with
alkaline phosphatase-labeled mAb 8 .3 (anti-Ighl , allotype cross-
reacting with Igh1° allotype) or mAb 5.7 (specific for Ighlb allo-
type) (Pharmingen, San Diego, CA) before incubation with the
substrates.
Detection ofAutoantibodies.
￿
ANAwere detected by indirect im-
munofluorescence using mouse kidney cryosections and FITC-
labeled goat anti-mouse Ig specific reagents (Southern Biotech-
nology Associates Inc.) as previously described (42) . For the deter-
mination ofANA, the initial serum dilution was 1:10; the highest
serum dilution at which specific immunofluorescence was seen was
called the titer.
Thepresence of anti-DNA antibodies was assessed by an ELISA
as previously described (42) . For the detection of anti-dsDNA and
anti-dDNA, a preparation ofdsDNA was obtained by extraction
from mouse liver according to Maniatis et al . (44) . ssDNA was
Autoimmunity in SCID Mice with NZB x NZW Fl Pre-B Cellsobtained by boiling the dsDNA solution for 15 min and cooling
on ice . A serum pool obtained from 10-mo-oldMRLlpr/lpr mice
was used as a positive control . The serum levels ofanti-DNA anti-
bodies are expressed as relative concentrations to this serum pool.
In vivo bound anti-mouse red blood cells (MRBC) antibodies
(Coombs' antibodies) were detected by direct anti-MR-BC RIA as
described previously (45) . Briefly, 50 P1 ofa 2.5% MRBC suspen-
sion was incubated for 2 h at 4°C with 50 P,1 of 1251-labeled goat
anti-mouse IgG + IgM (H + L) representing -50,000 cpm
equivalent to 1 Ag of antibodies, in 1% BSA-PBS . After washing
three times, the radioactivity bound to the MRBC was counted
in a gamma counter.
Retroviral anti-gp70 antibodies were determined by indirect im-
munofluorescence on mus dunni cells infected with the ecotropic
Akv623 virus and the amphotropic 4070A virus on mink CC164
cells infected with the xenotropic viruses NZB c135 and C85L1 .
Uninfected cell lines were used as controls. All cell lines were kindly
provided by Dr. J . L . Portis (National Institutes of Health,
Hamilton, Montana) . The anti-gp70mAb 83A25 (46) recognizing
an epitope that is present on gp70 of all classes ofmurine leukemia
viruses (MuLds), was used as a positive control . Staining was per-
formed by incubating infected and uninfected cells with serial dilu-
tions of serum samples, followed by incubation with FITC-labeled
goat anti-mouse IgG + IgM . (H + L) antibodies before analysis
with a FACScanO instrument (Becton Dickinson&Co.) . Sera were
scored positive for anti-gp70 antibodies when there was at least
a twofold serum dilution difference between positive staining of
infected versus uninfected cells .
Clinical and HistologicalExaminations.
￿
Proteinuria, as indicator
ofrenal disease, was determined on freshly collected urine samples
by use of paper graded from 0 to 4' (Albustix . Miles Laborato-
ries, Inc., Slough, UK) . Positive proteinuria was defined as >3+
(protein concentration >300 mg/dl). Three SCID mice injected
with B/W pre-B cells exhibiting proteinuria were killed for fur-
ther investigation of their renal disease . The presence of Ig deposits
in kidney glomeruli as well as Ig-producing cells in spleen and lymph
nodes were detected by direct immunofluorescence on cryosections
incubated 45 min with FITC-labeled goat mouse IgM-specific or
mouse IgG Fc fragment-specific FITC-labeled goat antibodies diluted
1:20 in PBS, followed by washing with PBS . Moreover, spleen,
lymph nodes, kidney, lung, liver, heart, and salivary gland from
SCID mice injected with BDF, or B/W pre-B cells and from age-
matched control SCID mice were fixed in 10% neutral buffered
formalin and prepared for microscopy analyses according to stan-
dard techniques .
Results
Establishment and Characteristics ofB/W Fetal Liver Pre-B
Cell Lines. Two pre-B cell lines proliferating for several
months on stromal cells in the presence ofrIL7, called B/W4
and B/W13, were established from fetal liver ofB/W mice
at day 17 of gestation and compared with two BDF, fetal
liver-derived pre-B cell lines with the same growth charac-
teristics called clone 8 and PAL-1 (32) . All lines expressed
the pre-B cell-specific antigen, PB76, the pan B cell-specific
antigen B220, andmRNA for the pre-B cell-specific genes
VpreB and A5 . However, they did not express g.H and KL
chain on the surface. Upon removal of IL-7, they differen-
tiated to sIgM-positive, LPS-reactive B cells, as assessed by
the capacity of the pre-B cell lines to generate IgM plaque-
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forming cells in the absence of IL-7 and the presence ofLPS .
The frequency of IgG-secreting cells developed in the pres-
ence ofLPS from the B/W cell lines was no more than 10%
of all Ig-secreting cells and was indistinguishable from BDF,
pre-B cell lines.
IgM-Hypergammaglobulinemia in SCID Mice Injected with
B/Wpre-B Cells. Previous experiments (32) had shown that
injection of 5 x 10 6 cells from several BDF, fetal liver pre-
B cell lines into CB17SCID mice populated their spleen within
6-8 wk to 5-10% of the normal levels of slg+ B cells. This
level remained constant for at least 25 wk . No donor-derived
T cells or myeloid cells could be found in these pre-B cell-
populated SCID mice, indicating that these pre-B cells could
be regarded as stem cells committed to the B lineage. This
capacity of in vivo differentiation was then tested with the
B/W pre-B cell lines . SCID mice were injected with a pool
ofB/W4 and B/W13 pre-B cells . Concentrations of serum
IgM were measured each month posttransfer until month
5 . In three separate experiments, 5-10 female SCID mice re-
ceived 5 x 106 (Fig. 1 A) or 10 x 106 pre-B cells (Fig. 1
B) and 10 male SCID mice received 15 x 106 pre-B cells
(Fig . 1 C) . For comparison, five female SCID mice were in-
jected with 5 x 106 BDF, pre-B cells of either clone PAL-1
or clone/8 (Fig . 1A) . Within the first 2-3 mo, all the mice,
male or female, injected with B/W pre-B cells developed
markedly elevated serum levels of IgM which were almost
as high as those of age-matched 4-5 mo-old B/W mice. The
serum levels ofIgM then remained constant during the period
of observation . In contrast, SCID mice injected with BDFI
pre-B cells developed serum IgM levels comparable with those
of adult BDF, mice, and no IgG .
IgG-Hypergammaglobulinemia in SCID Mice Injected with
B/WPre-B Cells. The sera ofthe SCID mice were also tested
for the presence of the four subclasses ofIgG. Results in Fig .
1 show that the SCID mice populated with B/W pre-B cells
contained all IgG subclasses in detectable concentrations,
whereas those injected with pre-B cells of normal BDF I
mice had almost no detectable levels of any IgG subclass .
Levels of IgG1 and IgG2b were lower than those found
inB/W mice or in normal mice, indicating that the intrinsic
B cell abnormality is not a general effect on all classes and
subclasses. We conclude that normal levels of IgG1 and IgG2b
are at least partly dependent on environmental influences.
Mean levels of IgG2a were as high as those of normal mice
and some individual mice had levels comparable with those
ofB/W mice . Thus, the high production of IgG2a is likely
to be a property of the B lineage cells themselves, and not
that of the environment in which theB lineage cells develop,
proliferate, and differentiate . Levels ofIgG3 were two-to-three
times as high as those of normal mice and were comparable
with those of B/W mice. Thus, like in the case of IgG2a,
the high production of IgG3 is likely a property of the B
lineage cells themselves, and not that of the environment .
No differences could be found between female (Fig. 1, A
and B) and male (Fig . 1 C) SCID mice populated with B/W
pre-B cells, indicating that the sex of the environment does
not influence the hypergammaglobulinemia in any of the Ig1346
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Kinetics of appearance ofIgM and IgG subclasses in the sera
of individual SCID mice populated with 5 x 106 (A), 10 x 10 6 (B), and
15 x 106 (C) BDF 1 (O) orB/W (" ) pre-B cells . Ig concentrations are
expressed in Ag/ml . For comparison, the mean values of serum IgM and
IgG concentrations of 10 3-4-mo-old BDFI and ten 4-5-mo-old B/W
mice are given as broken and continuous lines, respectively.
classes and subclasses tested . Serum levels of IgA were around
150 /Ag/ml inSCID mice populated with eitherB/W or with
BDFI pre-B cells, much lower than those of B/W (1.2
mg/ml) or BDFI (2 mg/ml) mice. This indicates that a low
level of serum IgA is maintained by pre-B and B cells in the
SCID environment, i.e., in the absence ofT cells . The levels
of IgA in BDFI and B/W mice are dependent on the envi-
ronment of amouse with complete lymphoid compartments,
e.g., with T cells .
The origin of the serum Ig in the SCID mice populated
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with pre-B cells could be investigated by an antiallotype assay,
since donor pre-B cells are Ighe, whereas CB17 SCID hosts
are Ighb . In the ELISA assay (see Materials and Methods),
we took advantage of the crossreactivity of an anti-IgG2a
mAb (mAb 8.3) with Ighl' and IghP allotypes but not
with Igh1b allotype . The IgG2a produced by SCID mice in-
jected with B/W pre-B cells expressed the Ighle allotype at
20 to 50 times higher levels than the IgH1b allotype of the
SCID host which was barely detectable (i.e., <50 NAg/ml),
indicating that the serum Ig was produced by the B/W B
lineage cells (data not shown) .
Spontaneous IgG Antinuclear andAnti-DNA Antibody For-
mation in SCID Mice Injected with B/W Pre-B Cells. The
production ofANA was examined in the sera ofSCID mice
injected with either B/W or BDFI pre-B cells . The data in
Fig. 2 A are presented as the cumulative incidence of mice
positive forANA in total Ig. 90% of the mice injected with
B/W pre-B cells were found to produce significant amounts
ofANA . In contrast, none of the mice injected with BDFI
pre-B cells demonstrate detectable ANA formation . All mice
injected with B/W pre-B cells produced ANA ofIgG class,
whereas -20% also had ANA of IgM isotype (Fig. 2 B) .
90% of the ANA-positive mice produced these antibodies
within3-mo posttransfer, whereas a similar incidence ofIgG
ANA occurs in B/W mice at only 9-mo of age (2, 14) . As
shown in Fig. 2 C, the titers of IgGANA continuously in-
crease with time. The predominant IgG subclass in ANA
is IgG2a . Despite low serum levels of total IgG2b, this sub-
class is also represented in ANA antibodies.
The sera ofSCID mice injected with pre-B cells were fur-
Autoimmunity in SCID Mice with NZB x NZW F1 Pre-B Cellsther investigated for the presence of anti-DNA antibodies .
Fig. 3 shows that none of the SCID mice injected with
BDFI pre-B cells produced detectable levels of IgM and IgG
anti-DNA antibodies . In contrast, the SCID mice injected
withB/W pre-B cells had elevated serum levels ofbothIgM
and IgG anti-DNA antibodies. In several mice their levels
were even higher than those in 4-5-mo-oldB/W mice . The
incidence of IgM anti-DNA antibody formation in SCID
mice 3 mo after injection of B/W pre-B cells does not
significantly differ from age-matched B/W mice (Fig . 3 A),
whereas the incidence of IgG anti-DNA antibody in these
SCID mice is significantly higher than in age-matchedB/W
mice (Fig . 3 B) . Analysis ofIgG subclass distribution of anti-
DNA antibodies in 20SCID mice 3 mo after population with
B/W pre-B cells revealed a higher incidence ofmice producing
IgG2a (13/20) andIgG3 (11/20) anti-DNA antibodies, than
mice producing IgG1 (4/20) and IgG2b (6/20) anti-DNA
antibodies . Thus, the predominance of the IgG2a subclass
among bothANA andanti-DNA antibodies inB/W popu-
lated SCID mice is similar to that seen in B/W mice (16) .
Since the appearance ofIgG anti-dsDNA antibodies corre-
lates closely with the renal disease in B/W mice (27), the
sera ofSCID mice populated with B/W pre-B cells were ana-
lyzed for the presence of IgG anti-dsDNA antibodies incom-
parison with IgG anti-ssDNA antibodies. The specificity of
the assay for anti-dsDNA antibodies was evident from the
fact that some mice with elevated serum levels of antibodies
to ssDNA were negative in the assay for antibodies todsDNA .
Results in Fig . 4 show that 9 of 14 SCID mice at 6-7 mo
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Kinetics of appearance of IgM (A) and IgG (B) anti-DNA
antibodies in the sera of individual SCID mice populated with BDF, (O)
or B/W (" ) pre-B cells. For comparison, serum levels of IgM and IgG
anti-DNA antibodies of 10 3-4-mo-old BDF, and 10 4-5-mo-old B/W
mice are given . Serum levels of anti-DNA antibodies are expressed as rela-
tive concentrations to a serum pool of 10 mo-old MRLlpr/lpr mice that
have high levels of anti-DNA antibodies .
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Serum levels of IgG
anti-dsDNA (" ) and IgG anti-
ssDNA (O) antibodies in in-
dividual 3-4-mo-old BDFI, 4-5
mo-old B/W, and SCID mice
repopulated withB/W pre-B cells
6-7 mo posttransfer. Serum levels
of anti-DNA antibodies are ex-
pressed as relative concentrations
ta pool serum of 10 mo-old o
MRLIpr/lpr mice.
Figure 5 .
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Absence ofCoombs'
type erythrocyte-specific autoan-
tibodies in SCID mice populated
withB/W pre-B cells. Results are
expressed as cpm x 10-3 1251_
labeled goat anti-mouse mIgG +
IgM (H + L) bound to a 2.5%
RBC suspension from 4-6-mo-
old BDFI mice, 6-8 mo-oldNZB
mice, and SCID mice repopulated
with BDFI or B/W pre-B cells
at 6 mo posttransfer. Each point
represents the value obtained with
an individual animal . (--- ) The
mean of control values of 4-6-mo-old BDFI mice and (
￿
) the mean
± 3 SD. All negatives were also negative in a haemagglutination assay
(data not shown) .
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after transfer ofB/W pre-B cells had significant serum levels
of IgG anti-ssDNA antibodies, and 6 of the 14 mice ana-
lyzed also contained IgG anti-dsDNA antibodies .
AbsenceofAntibodies against Erythrocytes andRetroviralgp70.
The presence of erythrocyte-specifc autoantibodies in SCID
Table 1 .
￿
Absence of Retroviral anti-gp70 Antibodies in Sera of
SCID Mice Populated with B/W pre-B Cells
SCID/B/W
The binding activities of the 83A25 hybridoma culture supernatant and
of mouse sera with antibodies specific for retroviral, env-encoded
glycoprotein gp70 was determined by indirect immunofluorescence on
cell lines infected with ecotropic, xenotropic, and amphotropic MuLVs,
using a FITC-labeled goat anti-mIgG + IgM (H + L) and a FACScan®
analyzer (see Materials and Methods) . Uninfected cell lines were used
as a control. The 83A25 hybridoma culture supernatant serum pool of
3-4-mo-old BDFI mice, one of 4-5 mo-old B/W mice, and five in-
dividual SCID mice populated withB/W pre-B cells at month 4-5 post-
transfer were titrated by serial twofold dilutions from 1:2 to 1:800 . Sera
were scored positive when there was at least a twofold serum dilution
difference between positive staining of infected versus uninfected cells .
30-
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5
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.b 0_ ss:s ss~sss =~~
BDFI BW SCID/BW
Virus mAb 83A25 BDF, B/W
Ecotropic
AKV623 + - +
Xenotropic
NZBC1 .35 + - +
CSSLl + - +
Amphotropic
4070A + - +mice populated with B/W pre-B cells was tested by the
Coombs' test . The results in Fig. 5 show that SCID mice
populated with either BDFI or B/W pre-B cells did not
contain autoantibodies specific for erythrocytes. In fact, none
of the SCID mice injected with B/W pre-B cells showed
any sign of anemia during the observation period as assessed
by hematocrit measurements (data not shown) .
The presence of antibodies against retroviral elements, in-
cluding gp70, in the sera described above was tested by
FACScan® analysis with mouse cells infected with am-
photropic, ecotropic, or xenotropic MuLVs. Uninfected cells
were used as a negative control . An antibody reacting with
all gp70s, mAb 83A25, was used as a positive control (46) .
The results, summarized in Table 1, show that sera of age-
matched B/W mice contain detectable quantities of retroviral
gp70- or other retroviral element-specific antibodies . In con-
trast, those of age-matched BDFI mice and of SCID mice
populated with either BDFI or with B/W pre-B cells did
not contain any detectable antiretroviral gp70 antibodies .
Clinical and Histological Analysis ofSCID Mice Injected with
B/W pre-B Cells. An important hallmark of SLE-like dis-
ease of B/W mice is the development of proteinuria, pos-
sibly as a consequence ofthe deposition of IgGimmune com-
plexes in the glomerula of the kidneys . About 20% ofB/W
mice had developed proteinuria at 7-mo of age, and almost
all of them at 11-mo of age (14, 27) . Until month 7 post-
transfer, we observed that 5 of the 25 SCID mice injected
with B/W pre-B cells developed proteinuria. At that time,
the animals were killed for histopathological analysis. Im-
munofluorescence studies on frozen sections of kidneys from
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SCID mice populated withB/W pre-B cells and having pro-
teinuria, demonstrated a faint positive staining of the glo-
merular basement membranes with IgG antibody in a linear
and slightly granular fashion. No proteinuria or IgG deposi-
tion in the kidneys was found in control SCID mice popu-
lated with BDFI pre-B cells . Thus, SCID mice injected with
B/W pre-B cells develop a similar although less severe kidney
disease as B/W mice. Further histological analysis of SCID
mice injected with BDFI pre-B cells and B/W pre-B cells
revealed that the white pulp of the spleens of SCID mice
injected with BDFI pre-B cells was repopulated by rather
densely patched donor-derived lymphocytes (Fig. 6, A and
B), which stained positive for sIgM (data not shown) . Peri-
arteriolar sheets often contained moderate to few lympho-
cytes. Plasma cells were virtually absent and germinal centers
were not found . Lymph nodes contained few lymphocytes.
Few plasma cells with cIgA were found in the lamina propria
of the gut . The level of hematopoiesis in the sternum was
regular but increased in the spleen . Liver, lung, kidney, and
salivary gland were regular and without lymphoid infiltration .
The white pulp of the spleen of B/W pre-B cell injected
SCID mice contained numerous small- and medium-sized lym-
phocytes and often was slightly larger than in SCID mice
injected with BDF, pre-B cells (Fig. 6, C and D) . In addi-
tion, a large number of plasma cells was found in these areas
and along some vessels . Moreover, intracytoplasmic droplets
of Ig were detected in some plasma cells giving rise to Rus-
sell bodies in Mott-type cells . A relatively large number of
the cells stained brightly forcIgM and/or for cIgG (data not
shown) . Germinal centers were not present . Lymph nodes
x NZW F l Pre-B Cells
Figure 6 .
￿
Giemsa stain of spleen
of a SCID mouse injected with
BDFI pre-B cells (A and B) and
B/W pre-B cells (C and D) . (A and
B) Small white pulp without ger-
minal centers with densely packed
small lymphocytes, but no plasma
cells . (A) x 20 . (B) x 80 . (C andD)
Large white pulp containing lym-
phocytes and numerous plasma cells.
(C)
￿
x 20. (D) x 80 .contained depleted paracortical (T) areas and some lympho-
cytes in the subcapsular (B) areas . In the gut, some cIgA+
plasma cells were present in the lamina propria, but not Peyer's
patches. The hematopoiesis in the sternum of these mice was
regular and increased in the spleen . Liver, lung, and salivary
gland were regular and without lymphoid infiltrations .
Discussion
The autoimmune disease in B/W hybrid mice is charac-
terized by hypergammaglobulinemia in the IgM and IgG
classes in the wake of a polyclonal activation ofB cells, and
by the production of autoantibodies to antigens in the nu-
cleus and on the surface of cells and to endogenous retroviral
gp70 . It leads to immune complex-type glomerulonephritis
resembling human lupus (1, 2, 9, 10) . Antibodies to erythro-
cytes develop late and, in NZB mice, lead to fatal hemolytic
anemia (1) . All these disease manifestations are under the con-
trol of a variety of genes contributed either by the NZB or
theNZW strains (8, 20-27) . It has long been suspected that
some of the genes exerting the disease in B/W hybrid mice
are, in fact, expressed in theB lymphocyte lineage, but a dis-
tinction from an action of an abnormal environment of stromal
cells, T cells, or macrophages inducing abnormal changes in
normal pre-B or B cells could not be made . The recent dis-
covery that precursor B cells expanding in long-term cultures
can populate for long periods of time some of the B cell com-
partments and no other cellular compartments ofSCID mice
Anemia
Lymphoid infiltrations
Proteinuria
Glomerulonephritis
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(32), allowed us to assess the influence and mode of action
of disease-determining genes in B cells independently from
the influence of other cell types. The results presented in this
paper distinguish genetic defects of theB/W mice expressed
in B lineage cells from others that are not expressed in this
cell lineage without the help of cooperating cells absent in
SCID mice, notably T cells . Table 2 summarizes the results
ofSCID mice repopulated with BDFI and B/W pre-B cells
as presented in this paper, and compares these to findings
made in normal BDFI and B/W mice .
The rather constant levels of serum Ig, particularly ofIgM
in the SCID mice, after the first and for the next 4 mo after
population with B/W pre-B cells argue for long-term recon-
stitution ofsome of the B cell compartments in these mice.
It is reasonable to assume that IgM has the normal short half-
life of a few days in serum and that, consequently, IgM-
secreting plasma cells must exist in numbers sufficient to
replenish and keep up the elevated levels. The half-life of these
IgM-producing plasma cells is not known at present, but it
is probable that there is a considerable turnover occurring
in vivo. For their continuous generation, B cells and prob-
ably pre-B cells must continuously proliferate and differen-
tiate. The same argument should apply for IgG-secreting cells .
Future experiments will have to evaluate which cellular stage
of B cell development, and in which numbers, contribute
to the long-term establishment of the hyperplastic and hyper-
gammaglobulinemic states ofthe autoimmune diseaseSCID
mouse originally populated with B/W pre-B cells.
Table 2 . Immunological and
Defect in B/W
Clinical Parameters of BDF,
BDF,
mice
andB/W Mice and ofSCID
SCID mice
with BDF, pre-B
Mice Repopulated with
B/W
mice
BDF, or B/WPre-B cells
SCID mice with
B/Wpre-B
IgM plasma cell hyperplasia - yes yes
Levels of serum IgM normal normal elevated elevated
IgG plasma cell hyperplasia no no yes yes
Levels of serum IgG2a normal not detectable elevated normal-elevated
Levels of serum IgG3 normal not detectable elevated elevated
Levels of serum IgG1 normal not detectable elevated low
Levels of serum IgG2b normal not detectable normal low
Levels of serum IgA normal low normal low
ANA antibodies + + accelerated
anti-ssDNA + + accelerated
anti-dsDNA + ( + ) less frequent
gp70-specific antibodies
Antierythrocyte antibodiesSo far, we have not observed the development ofT cells
from pre-B cell clones (32) . However, we cannot definitely
rule out the participation of T cells, since SCID can occa-
sionally become leaky, i .e . can produce low levels of func-
tional T cells (47) . FACS® analyses on the SCID lymphoid
organs have occasionally revealed the presence of CD3+,
CD4+, or CD8+ T cells (data not shown) . These T cells
were found mainly in the peritoneal cavity, both in nonin-
jected SCID mice, as well as those populated with BDFI or
B/Wderived pre-B cells. Like others (48), we observed the
frequent appearance of CD4, CD8 double-positive TCR-
cx/i(3 - , .y/S - T cells, i .e ., nonfunctional T cells in the
thymus of old SCID mice. These T cells often give rise to
T cell leukemias (our own unpublished observations), which
has hampered a follow-up of the pre-B cell-populated SCID
mice for longer than 7-8 mo. Taken together, the observed
SLE-like disease in the SCID mice populated with B/W pre-B
cells is likely to be a T cell-independent process .
Defects that are expressed in the B lineage of B/W mice
alone, and that lead to IgM-hypergammaglobulinemia, switch-
ing to IgG, IgG-hypergammaglobulinemia in the IgG2a and
IgG3 subclasses, plasma cell hyperplasia, and elevated serum
levels ofIgG-ANA and IgG anti-dsDNA autoantibodies are
likely to be the result of several genetic factors . Particularly
intriguing is theT cell-independent switching to IgG2a and
IgG3 . The genes for the two IgG subclasses are found at the
opposite ends of the IgG-gene cluster and switching to them
is probably regulated by different cytokines, all indications
that the defects could be controlled by separate genes. B/W
mice carrying the xid mutation show reduced polyclonal B
cell activation (49), no anti-DNA autoantibodies, and no renal
disease (50) . Since the xid mutation interferes with develop-
ment ofB cells involved in type two T cell-independent (TI-2)
antibody responses (51, 52), possibly these defects ofB/W B
lineage cells expressed in these mice might reside in this B
cell population. A comparison of genes expressed in B/W
(or NZB)-derived pre-B cells and those expressed in pre-B
cells derived from normal nonautoimmune strains of mice
might yield clues about this B cell defect. Pre-B cells gener-
ated from a series of recombinant inbred strains of NZB x
C58 mice should also allow a further dissection of genes
affecting the different manifestations of the NZB- andNZW
controlled autoimmune disease and its final fatal outcome (23) .
Whereas in the B/W mice kidney failure is the final fatal
stage, homozygous NZB mice develop a late autoimmune
disease with polyclonal B cell activation and autoantibody
production in which the anemia exerted by the erythrocyte-
specific antibodies dominates the fatal outcome of the disease
(14) . Experiments are now in progress to develop pre-B cell
lines and clones of these NZB mice to populate the SCID
and test the development of serologic and pathologic manifesta-
tion ofautoimmune disease. B cell abnormalities appear also
to be involved in other models of SLE-like autoimmune dis-
eases like mice carrying the lpr gene andBXSB mice. By using
double chimeras with combinations of congenic strains
differing at theIgH and lpr loci, Sobel et al . (53) could dem-
onstrate that the production of autoantibodies in lpr mice
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requires expression of the lpr gene in their B cells . Similarly,
Merino et al. (54) demonstrated that a selective activation
of B cells bearing the Y chromosome of BXSB origin in
double-congenic chimeric mice leads to hypergamma-globu-
linemia and autoantibody production . Here again, the ex-
pression ofB cell abnormalities leading to spontaneous au-
toimmune disease might be dependent or independent ofthe
environment of stromal cells, T cells, or macrophages, and
this influence of the environment on B cells should be testable
in our system .
Abnormalities not expressed by B lineage cells alone, i .e .,
in the normal environment of the CB17 SCID mice, are
erythrocyte-specific antibodies, although B/W mice make little
of this specificity, and retroviral anti-gp70 . The genes leading
to autoimmune hemolytic anemia have been mapped to chro-
mosome 4 of the NZB mouse near the mup-1 locus (24) .
They are unlinked to genes controlling the development of
autoantibodies specific for histones, dsDNA, and retroviral
gp70 . The latter responses are controlled by genes linked to
each other, which have been mapped to chromosome 17 of
theNZW mouse near or within the MHC-locus (8, 25, 26),
which could be interpreted to mean that these autoantibody
responses areMHC restricted and T cell dependent, or that
they are controlled by other genes within this chromosomal
region expressed in other cell lineages . Since SCID mice with
B/W pre-B cells and with B cells differentiating from them
lack the normal T cell compartments, the absence of these
antierythrocyte antibodies and retroviral gp70 antibodies sup-
ports the notion that their development might be T cell de-
pendent . The fact that dsDNA-specific antibodies of the IgG
class occur in some SCID mice populated with B/W pre-B
cells indicates that at least some of these antibodies can be
formed in a T-independent stimulation ofB cells. Although
controversial, further evidence for functions ofT cells in SLE-
like disease in B/W mice comes from experiments that ana-
lyzed the effect of thymectomy, or studied the influence of
the nude mutation in B/W mice (55-57) . Wofsy et al . (30)
reported that treatment ofB/W mice with anti-CD4 mAb
markedly diminished the anti-DNA antibody titers and
prevented the development of renal disease in these animals .
Although CD4 is also expressed on multipotential hemato-
poietic precursors (58), and thus, anti-CD4 mAb treatment
might also affect these cell populations, these data have been
interpreted in favor of a role ofT cells in the autoimmune
disease observed in B/W mice. Finally, since helper T cells
not only induce switching to IgG but also somatic hyper-
mutation of IgV regions ofH and L chain genes expressed
in normalB cells, it will be interesting to see whetherB/W
derived B cells in SCID mice not only switch to IgG, but
also hypermutate without the help of T cells.
Our experiments demonstrate that defects expressed in B
lineage cells of B/W mice alone suffice to develop a renal
disease. Even without specific autoantibody production against
retroviral gp70, the presence of ANA antibodies or simply
high levels ofIgM and IgG appear sufficient to develop the
disease, although maybe at a slower rate. This finding fur-
ther supports the suspicion that IgG2a ANA are important
Autoimmunity in SCID Mice with NZB x NZW Fl Pre-B Cellsin the development of the B/W kidney disease (11, 15, 25) .
A possible role for T cells enhancing the disease could be
seen in the generation ofmore pathogenic autoantibodies (4)
or in the generation oferythrocyte- or gp70-specific autoan-
tibodies, or in an increased formation ofanti-dsDNA anti-
bodies (26),'all of which could accelerate the destruction of
the glomeruli of the kidney byimmune complexes. The SCID
mice populated with B/W pre-B cells offer the unique op-
portunity to test the influence of different T cell populations
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